Clinical Trial Update: ctDNA for Early Detection of Recurrence in Melanoma

View source ↗

Summary

An update on a trial evaluating ctDNA for the early detection of melanoma recurrence. The study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Herlev and Gentofte Hospital | Conditions: Melanoma | Status: ACTIVE_NOT_RECRUITING